Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Insulin Resistance 1Endocrine System Diseases 1

Interventions

Metformin 35Clomiphene 11Letrozole 10Inositol 7Triptorelin Pamoate 5drospirenone and ethinyl estradiol combination 4Progesterone 4Folic Acid 4Ethinyl Estradiol 4Caloric Restriction 4drospirenone 3cetrorelix 3Spironolactone 3Estradiol 3Diet, Mediterranean 3Diet 3Cyproterone acetate, ethinyl estradiol drug combination 3Contraceptives, Oral 3Acupuncture Therapy 3adrenosterone 2Vitamin D 2Ultrasonography 2Thioctic Acid 2Therapeutics 2Sitagliptin Phosphate 2Simvastatin 2Pioglitazone 2Ovidrel 2Musculoskeletal Manipulations 2Hematologic Tests 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Polycystic Ovary Syndrome × Dehydroepiandrosterone × Clear all
NCT05263557 2023-07-25

DIMOXIS

Royal College of Surgeons, Ireland

Phase NA Unknown
20 enrolled

Endocrine System Diseases, Insulin Resistance, Polycystic Ovary Syndrome

NCT05246865 2022-11-02

11OXO-PCOS

University of Birmingham

Phase NA Unknown
100 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡